FDA Chlorthalidone dissolution testing recall: More than 25,000 bottles of blood pressure medication recalled. Check which tablets are impacted?

Blood Pressure tablets FDA chlorthalidone dissolution testing recall: Chlorthalidone medication is prescribed to keep the blood pressure in check. The pills generally decrease the water and salt in the body through uptick in urine flow.

BCCL - Non Copyright

FDA Chlorthalidone dissolution testing recall Blood Pressure tablets

FDA Chlorthalidone dissolution testing recall: Over 25,000 bottles of blood pressure medication have been recalled for improper dissolution. Reports claim that India based Inventia Healthcare Limited has made the two recalls, U.S Food and Drug Administration (FDA) reported.

Improper dissolution can lead to ineffectiveness of the drug.

Two recalls were made on June 5 and September 3 respectively as part of FDA class II recall. On the first occasion, 11,460 bottles were recalled, and on the second time 13,567 bottles were recalled.


Inventia Healthcare Limited's recall include 25 milligram chlorthalidone tablets such as RISA24001, RISB24002, and RISA24002.

Chlorthalidone medication is prescribed to keep the blood pressure in check. The pills generally decrease the water and salt in the body through uptick in urine flow.

Earlier also, the U.S. Food and Drug Administration revealed that drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
ADVERTISEMENT

New Jersey-based Teva Pharmaceuticals USA and drugs distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month of more than 580,000 bottles of various strengths of prazosine capsules, according to the FDA.

Doctors prescribe prazosin, which relaxes blood vessels, to help lower blood pressure. It also is sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder.

The FDA said in enforcement orders posted online that it has given the affected lots of the drug a Class II risk classification because some of the recalled medication may have nitrosamine impurities that are considered potentially cancer causing.

According to the FDA, N-nitrosamine impurities are a class of potentially cancer-causing chemicals that can form during manufacture or storage of a drug.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › US News › FDA Chlorthalidone dissolution testing recall: More than 25,000 bottles of blood pressure medication recalled. Check which tablets are impacted?
Text Size:AAA
Success
This article has been saved

*

+